Korean J Med.  2000 Aug;59(2):192-197.

A case of cerebellar embolic infarction in thyrotoxic atrial fibrillation

Affiliations
  • 1Department of Internal Medicine, St. Benedict Hospital, Pusan, Korea.

Abstract

Atrial fibrillation occurs in 10 to 25% of patients with thyrotoxicosis. Several recent studies have found a high frequency of cerebral thromboembolism in such patients. Thus anticoagulation has been recommended for patients with thyrotoxic atrial fibrillation to prevent embolic complications especially when associated with predictors of an increased risk of arterial thromboembolism in nonrheumatic atrial fibrillation such as recent congestive heart failure, history of hypertension, previous thromboembolism, left atrial enlargement, and global left ventricular dysfunction. Most reported cases of embolic events involving central nervous system in thyrotoxic atrial fibrillation affected cerebrum, and cerebellar embolic infarction from the heart was rarely seen. We herein report our experience of a case of cerebellar embolism in thyrotoxic atrial fibrillation.

Keyword

Nimesulide; Hypersensitivity; Hepatitis; toxic

MeSH Terms

Atrial Fibrillation*
Central Nervous System
Cerebrum
Embolism
Heart
Heart Failure
Hepatitis
Humans
Hypersensitivity
Hypertension
Infarction*
Thromboembolism
Thyrotoxicosis
Ventricular Dysfunction, Left
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr